MicroRNA-449a reduces cell survival and enhances cisplatin-induced cytotoxicity via downregulation of NOTCH1 in ovarian cancer cells

Epithelial ovarian cancer (EOC) is the leading cause of death from gynecologic malignancies. Platinum-based chemotherapy is the first-line treatment for the advanced ovarian cancer, but resistance to cisplatin remains a major obstacle to successful treatment. MicroRNAs (miRNAs) are a class of non-coding RNAs that play important roles in disease processes, including the development of drug resistance. In this study, we found miR-449a were significantly downregulated in the cisplatin-resistant ovarian cell lines SKOV3/DDP and A2780/DDP, compared with their sensitive parent line SKOV3 and A2780, respectively. The overexpression of miR-449a increased cisplatin sensitivity of SKOV3/DDP and A2780/DDP cells by inhibiting proliferation and promoting apoptosis. The luciferase assay confirmed that miR-449a functioned through suppressing NOTCH1 directly. Concordantly, BALB/c nude mice that were injected intraperitoneally with SKOV3/DDP cells transfected with miR-449a mimics exhibited enhanced cisplatin sensitivity in vivo. Taken together, these results suggest that the ectopic expression of miR-449a may be a promising therapeutic strategy for the management of cisplatin resistance in ovarian cancer.

[1]  D. Green,et al.  Apoptosis and cancer. , 1994, Important advances in oncology.

[2]  Jie Huang,et al.  Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy. , 2014, Biochemical and biophysical research communications.

[3]  Ying Song,et al.  microRNA-449a functions as a tumor-suppressor in gastric adenocarcinoma by targeting Bcl-2 , 2013, Oncology letters.

[4]  Thaned Kangsamaksin,et al.  Notch signaling in developmental and tumor angiogenesis. , 2011, Genes & cancer.

[5]  Lei Zhang,et al.  Involvement of microRNA‐93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells , 2012, FEBS letters.

[6]  R. Place,et al.  miR-449a targets HDAC-1 and induces growth arrest in prostate cancer , 2009, Oncogene.

[7]  Jie He,et al.  Report of incidence and mortality in China cancer registries, 2009. , 2013, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[8]  Jie He,et al.  Report of incidence and mortality in China Cancer Registries, 2008 , 2012, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[9]  Z. Siddik,et al.  Cisplatin: mode of cytotoxic action and molecular basis of resistance , 2003, Oncogene.

[10]  Piotr Zawierucha,et al.  Extracellular Matrix Proteins Expression Profiling in Chemoresistant Variants of the A2780 Ovarian Cancer Cell Line , 2014, BioMed research international.

[11]  D. Bowtell,et al.  Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers , 2011, PloS one.

[12]  Biliang Zhang,et al.  Tumor-suppressive microRNA-449a induces growth arrest and senescence by targeting E2F3 in human lung cancer cells. , 2014, Cancer letters.

[13]  R. Qin,et al.  miR-449a Regulates Proliferation and Chemosensitivity to Cisplatin by Targeting Cyclin D1 and BCL2 in SGC7901 Cells , 2014, Digestive Diseases and Sciences.

[14]  V. Brabec,et al.  Molecular aspects of resistance to antitumor platinum drugs. , 2002, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[15]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[16]  K. Geissler,et al.  Pathways involved in Drosophila and human cancer development: the Notch, Hedgehog, Wingless, Runt, and Trithorax pathway , 2012, Annals of Hematology.

[17]  D. Ma,et al.  Silencing of the STAT3 signaling pathway reverses the inherent and induced chemoresistance of human ovarian cancer cells. , 2013, Biochemical and biophysical research communications.

[18]  Gregory A. Wyant,et al.  Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy , 2012, Proceedings of the National Academy of Sciences.

[19]  Hua Han,et al.  Notch signaling pathway and cancer metastasis. , 2012, Advances in experimental medicine and biology.

[20]  Xiangyi Zheng,et al.  MicroRNA-449a acts as a tumor suppressor in human bladder cancer through the regulation of pocket proteins. , 2012, Cancer letters.

[21]  Huan Yang,et al.  MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. , 2008, Cancer research.

[22]  Anders Krogh,et al.  miR-449 inhibits cell proliferation and is down-regulated in gastric cancer , 2011, Molecular Cancer.

[23]  T. Dang.  Notch, apoptosis and cancer. , 2012, Advances in experimental medicine and biology.

[24]  G. Fu,et al.  MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance , 2011, Journal of Cell Science.

[25]  M. Dobbelstein,et al.  E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis , 2010, Cell Death and Differentiation.

[26]  Wei Zhu,et al.  miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2 , 2012, Medical Oncology.

[27]  Patricia A. Kruk,et al.  MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN (Cancer Research (2008) 68, (425-433)) , 2008 .

[28]  Min Liu,et al.  Plexin-B1 is a target of miR-214 in cervical cancer and promotes the growth and invasion of HeLa cells. , 2011, The international journal of biochemistry & cell biology.

[29]  P. Morin.  Drug resistance and the microenvironment: nature and nurture. , 2003, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[30]  Gang Chen,et al.  miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1 , 2011, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

[31]  Hua Zhang,et al.  MiR-489 modulates cisplatin resistance in human ovarian cancer cells by targeting Akt3 , 2014, Anti-cancer drugs.

[32]  L. Greco,et al.  MicroRNA-449a Overexpression, Reduced NOTCH1 Signals and Scarce Goblet Cells Characterize the Small Intestine of Celiac Patients , 2011, PloS one.

[33]  Xiaohong Zhao,et al.  Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells , 2011, Journal of experimental & clinical cancer research : CR.

[34]  M. Huang,et al.  Cisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating Notch signaling. , 2013, Cancer research.

[35]  B. Cullen,et al.  MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms , 2003, Proceedings of the National Academy of Sciences of the United States of America.